SCHEMBL24619338

SCHEMBL24619338

CC(C)(O)c1ccnc2c(F)cc(-c3nc(NC4CCN(S(=O)(=O)C5CC5)CC4)ncc3F)cc12

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CDK6 Q00534 18/20 0.49
▸ CCND1 P24385 17/20 0.49
▸ CCND3 P30281 16/20 0.49
▸ CDK4 P11802 15/20 0.49
▸ CCNE1 P24864 8/20 0.49
▸ CDK2 P24941 8/20 0.49
▸ CDK1 P06493 5/20 0.49
▸ CCNB1 P14635 5/20 0.49
▸ CCNT1 O60563 2/20 0.49
▸ CDK7 P50613 2/20 0.49
▸ CDK9 P50750 2/20 0.49
▸ CCNH P51946 2/20 0.49
▸ MNAT1 P51948 2/20 0.49
▸ CCNB2 O95067 1/20 0.47
▸ CCNE2 O96020 1/20 0.47
▸ CDK5 Q00535 1/20 0.47
▸ CDK5R1 Q15078 1/20 0.47
▸ CCNB3 Q8WWL7 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29727049 1.00 CDK6 (0.49) CDK6CCND1CCND3CDK4CCNE1
SCHEMBL24619627 0.93 CDK2 (0.56) CDK6CCND1CCND3CDK4CCNE1
SCHEMBL29727232 0.93 CDK2 (0.56) CDK6CCND1CCND3CDK4CCNE1
SCHEMBL29727182 0.92 CDK6 (0.47) CDK6CCND1CCND3CDK4CCNE1
SCHEMBL29727062 0.90 CDK6 (0.51) CDK6CCND1CCND3CDK4CCNE1
SCHEMBL24619227 0.90 CDK6 (0.51) CDK6CCND1CCND3CDK4CCNE1
Hydrochloric Acid SCHEMBL29727083 0.89 CDK6 (0.50) CDK6CCND1CCND3CDK4CCNE1
SCHEMBL24619098 0.87 CCND3 (0.49) CDK6CCND1CCND3CDK4CCNE1
SCHEMBL24619331 0.85 CCNE1 (0.47) CDK6CCND1CCND3CDK4CCNE1
SCHEMBL29727176 0.85 CCNE1 (0.49) CDK6CCND1CCND3CDK4CCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022149057-A1 CDK INHIBITORS RHIZEN PHARMACEUTICALS AG (CH) 2022-07-14 — — WO disclosed
Send feedback